Phase III studies of a gene therapy for Leber Hereditary Optic Neuropathy have generated some unexpected positive findings. There is biologic plausibility to explain the data.
Tools for higher-order OCT assessment enable evaluation of features of interest, such as targeted retinal layers or fluid compartments, and may allow for unique characterization of disease phenotypes and treatment response.
Doug Katsev, MD, takes a look at two key factors for patients suffering from vision loss who are also considering undergoing cataract surgery, including the association with age-related macular degeneration (AMD).
RSVP now to join Ophthalmology Times in recognizing winners of the 2019 Resident Writers Award Program. This unique opportunity promotes excellence in anterior segment education, acknowledging the best in case identification and written presentation skills.
Read more.
This is a post-only, outbound email. Please do not reply to this email as we will be unable to respond to your reply. Please use the links provided if you have questions or concerns regarding this email or your subscription.
This email was sent by: %%Member_Busname%% %%Member_Addr%% %%Member_City%%, %%Member_State%%, %%Member_PostalCode%%, %%Member_Country%%
Read more.
